XML 51 R21.htm IDEA: XBRL DOCUMENT
v3.20.1

License, Clinical Trial and Sponsored Research Agreements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
License Agreements [Member] |
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] |
Schedule of license, clinical trial and sponsored research agreements |
|  | For the year ended December 31,
($ in thousands) |  | 2019 |  | 2018
City of Hope |  |  |  |  |  |
CD123 |  | $ | 250 |  | $ | —
CS1 |  |  | 200 |  |  | —
PSCA |  |  | 200 |  |  | —
HER2 |  |  | — |  |  | 200
Manufacturing |  |  | — |  |  | 75
CSL Behring (Calimmune) |  |  | 200 |  |  | —
UCLA |  |  | 300 |  |  | —
St. Jude - XSCID |  |  | — |  |  | 1,000
Nationwide Children's Hospital - C134 |  |  | 200 |  |  | —
Fortress PIK Dividend |  |  | 4,923 |  |  | 2,085
Total |  | $ | 6,273 |  | $ | 3,360
Sponsored Research And Clinical Trial Agreements [Member] |
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] |
Schedule of license, clinical trial and sponsored research agreements |
|  | For the year ended December 31,
($ in thousands) |  | 2019 |  | 2018
City of Hope |  | $ | 2,000 |  | $ | 2,000
City of Hope - CD123 |  |  | 1,202 |  |  | 835
City of Hope - IL13Rα2 |  |  | 876 |  |  | 1,056
City of Hope - Manufacturing |  |  | 457 |  |  | 458
Fred Hutch - CD20 |  |  | 762 |  |  | 1,301
St. Jude - XSCID |  |  | 777 |  |  | —
BIDMC - CRISPR |  |  | 69 |  |  | 69
Total |  | $ | 6,143 |  | $ | 5,719

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 808 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mbio_LicenseAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mbio_SponsoredResearchAndClinicalTrialAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |